Endiandric acid H derivatives as c-maf inhibitors for using against asthma
Details for Australian Patent Application No. 2003250099 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 102 35 624.6 02.08.02 DE
8 April 2004 Application Open to Public Inspection
Published as AU-B-2003250099
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
18 December 2008 Application Accepted
Published as AU-B-2003250099
23 April 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser